ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,335Medicare Part D Prescriptions Filled, Including Refills

Rank: 37 out of 198

$699K Total Retail Price of All Prescriptions

Rank: 31 out of 198

403 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 403 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

13% of this provider’s 403 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 10,877 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
LEVOTHYROXINE SODIUM 579 520 1 1
OMEPRAZOLE 366 318 2 3
FUROSEMIDE 340 312 3 5
AMLODIPINE BESYLATE 325 322 4 4
WARFARIN SODIUM 305 301 5 7
SIMVASTATIN 290 274 6 2
LISINOPRIL 260 245 7 6
HYDROCODONE-ACETAMINOPHEN 233 169 S3 8 8
TRIAMTERENE-HCTZ 220 217 9 32
PRAVASTATIN SODIUM 208 192 10 19
CARVEDILOL 200 180 11 24
GABAPENTIN 169 162 12 14
ATORVASTATIN CALCIUM 161 148 13 12
TRAMADOL HCL 154 147 14 15
POTASSIUM CHLORIDE 152 137 15 9
TRAZODONE HCL 139 138 16 50
DONEPEZIL HCL 136 136 17 28
LOSARTAN POTASSIUM 133 132 18 18
ATENOLOL 132 107 19 17
PANTOPRAZOLE SODIUM 131 99 20 31
ZOLPIDEM TARTRATE 131 131 20 22
NAMENDA 130 130 22 33
METOPROLOL SUCCINATE 128 111 23 11
TAMSULOSIN HCL 127 101 24 27
HYDROCHLOROTHIAZIDE 121 102 25 16
FENOFIBRATE 115 115 26 61
ALENDRONATE SODIUM 114 98 27 21
MIRTAZAPINE 112 112 28 44
METOPROLOL TARTRATE 110 101 29 10
FLUOXETINE HCL 108 91 30 78
GLIMEPIRIDE 103 81 31 35
BYSTOLIC 98 98 32 58
PREDNISONE 97 91 33 29
RANITIDINE HCL 95 91 34 54
CELEBREX 91 84 35 59
LANTUS SOLOSTAR 90 68 36 85
POLYETHYLENE GLYCOL 3350 90 63 36 41
RAMIPRIL 87 85 38 72
METFORMIN HCL ER 84 62 39 64
DIOVAN 82 82 40 34
JANUVIA 79 79 41 86
CLOPIDOGREL 78 72 42 42
LISINOPRIL-HYDROCHLOROTHIAZIDE 77 76 43 38
CYMBALTA 75 51 44 48
PRIMIDONE 73 73 45 200
FLUTICASONE PROPIONATE 73 52 45 39
PAROXETINE HCL 71 66 47 65
ALLOPURINOL 68 51 48 23
CITALOPRAM HBR 66 60 49 20
CIPROFLOXACIN HCL 65 54 50 55
CRESTOR 65 65 50 26
SYNTHROID 64 51 52 36
ZETIA 64 51 52 68
CLONIDINE HCL 58 50 54 52
METFORMIN HCL 57 52 55 13
ISOSORBIDE MONONITRATE ER 56 56 56 60
ESCITALOPRAM OXALATE 55 47 57 53
DIGOXIN 54 51 58 43
HUMULIN N 53 52 59 176
PLAVIX 52 48 60 66
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.